Evidence map›Paper›PMID 39905313›Full record

ArticleBMC infectious diseases2025

Evaluation of pulmonary tuberculosis disease burden in Shenyang, China, 2023.

Huijie Chen, Haiyan Bi, Peng Li, Zhixing Yang, Lihai Wen, Baijun Sun, Wei Sun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Huijie Chen *Department of Infectious Disease, Shenyang Municipal Center for Disease Control and Prevention(Shenyang Municipal Health Supervision Institute), Shenyang, 110623, Liaoning Province, China.
Haiyan Bi *Department of Infectious Disease, Shenyang Municipal Center for Disease Control and Prevention(Shenyang Municipal Health Supervision Institute), Shenyang, 110623, Liaoning Province, China. bihaiyan2022@163.com.
Peng LiDepartment of Infectious Disease, Shenyang Municipal Center for Disease Control and Prevention(Shenyang Municipal Health Supervision Institute), Shenyang, 110623, Liaoning Province, China.
Zhixing YangDepartment of Epidemiology, China Medical University, Shenyang, 110122, Liaoning Province, China.
Lihai WenDepartment of Infectious Disease, Shenyang Municipal Center for Disease Control and Prevention(Shenyang Municipal Health Supervision Institute), Shenyang, 110623, Liaoning Province, China.
Baijun SunDepartment of Infectious Disease, Shenyang Municipal Center for Disease Control and Prevention(Shenyang Municipal Health Supervision Institute), Shenyang, 110623, Liaoning Province, China.
Wei SunKey Laboratory of Early Warning and Intervention Technologies and Countermeasures for Major Public Health Events in Liaoning Province, China Medical University, Shenyang, 110122, Liaoning Province, China. wsun@cmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPulmonary tuberculosis (PTB) is one of the most serious infectious diseases worldwide and poses a great threat to people's health. China has a vast territory with substantial regional disparities in the PTB disease burden. However, there have been no studies conducted to evaluate the PTB disease burden in Shenyang. The aim was to elucidate the magnitude, composition, and distribution of PTB disease burden in Shenyang.

methodsThe disability-adjusted life years (DALYs) calculated based on Global Burden of Disease (GBD) framework was used to assess the disease burden of PTB in Shenyang in 2023, and descriptive epidemiological methods were employed to elucidate the magnitude, composition, and distribution characteristics of PTB disease burden in Shenyang.

resultsIn 2023, 4,169 PTB cases were reported in Shenyang, including 2,901 males and 1,268 females. The incidence of PTB was 45.50/10

conclusionThe PTB DALYs rate in Shenyang was 58.25/10

Indexed as

Cost of IllnessTuberculosis, PulmonaryAdolescentAdultAgedAged, 80 and overChildChild, PreschoolChinaDisability-Adjusted Life YearsFemaleHumansIncidenceInfantInfant, NewbornMaleDisability-adjusted life yearDisease BurdenPulmonary tuberculosisShenyang

Identifiers

PMID39905313
PMCPMC11796274

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.